Estradiol variability, stressful life events, and the emergence of depressive symptomatology during the menopausal transition

Menopause

Volumn 23, Issue 3, 2016, Pages 257-266

  Gordon, Jennifer L ^a   Rubinow, David R ^a   Eisenlohr Moul, Tory A ^a   Leserman, Jane ^a   Girdler, Susan S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Estradiol fluctuation; Menopausal transition; Perimenopausal depression; Rejection sensitivity; Stress sensitivity; Stressful life events

Indexed keywords

ESTRADIOL; PROGESTERONE; ESTROGEN;

ADULT; ANGER; ANXIETY; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLIMACTERIUM; CONTROLLED STUDY; DEPRESSION; EMOTION; ESTRADIOL BLOOD LEVEL; ESTRADIOL VARIABILITY; ESTROGEN THERAPY; EXERCISE TEST; FEAR; FEMALE; FEMALE GENITAL TRACT PARAMETERS; HOSTILITY; HUMAN; LIFE EVENT; LIFE STRESS; MENTAL ARITHMETIC; MENTAL STRESS; POSTMENOPAUSE; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SOCIAL REJECTION; SOCIAL STRESS; STRESS; SYMPTOMATOLOGY; TRIER SOCIAL STRESS TEST; VERY STRESSFUL LIFE EVENT; BLOOD; DRUG EFFECTS; MIDDLE AGED; PREVENTION AND CONTROL; PSYCHOLOGIC TEST; PSYCHOLOGY; QUESTIONNAIRE; SELF REPORT;

ANXIETY; DEPRESSION; EMOTIONS; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; LIFE CHANGE EVENTS; MIDDLE AGED; PERIMENOPAUSE; PSYCHOLOGICAL TESTS; SELF REPORT; SURVEYS AND QUESTIONNAIRES;

EID: 84959907438     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0000000000000528     Document Type: Article

References (63)

1. Kessler RC. Epidemiology of women and depression. J Affect Disord 2003;74:5-13.
2. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157:924-930.
3. Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998;338:209-216.
4. Gordon JL, Girdler SS, Meltzer-Brody SE, et al. Ovarian hormone fluctuation, neurosteroids and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry 2015;172:227-236.
5. O'Connor KA, Ferrell R, Brindle E, et al. Progesterone and ovulation across stages of the transition to menopause. Menopause 2009;16:1178-1187.
6. Bromberger JT, Kravitz HM, Chang Y-F, Cyranowski JM, Brown C, Matthews KA. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychol Med 2011;41:1879-1888.
7. Bromberger JT, Matthews KA, Schott LL, et al. Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007;103:267-272.
8. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
9. Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Mariella A, Mitchell ES. Depressed mood during the menopausal transition and early post-menopause: observations from the Seattle Midlife Women's Health Study. Menopause 2008;15:223-232.
10. Avis NE, Crawford S, Stellato R, Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001;4:243-249.
11. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-382.
12. Daly RC, Danaceau MA, Rubinow DR, Schmidt PJ. Concordant restoration of ovarian function and mood in perimenopausal depression. Am J Psychiatry 2003;160:1842-1846.
13. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006;63:385-390.
14. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging WorkshopR 10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105-114.
15. Gordon JL, Girdler SS. Hormone replacement therapy in the treatment of perimenopausal depression. Curr Psychiatry Rep 2014;16:1-7.
16. Gibbs Z, Kulkarni J. Risk factors for depression during perimenopause. In: Women's Reproductive Mental Health Across the Lifespan. New York: Springer; 2014:215-233.
17. Gibbs Z, Lee S, Kulkarni J. The unique symptom profile of perimeno-pausal depression. Clin Psychol 2014;19:76-84.
18. Richard A, Rohrmann S, Mohler-Kuo M, et al. Urinary phytoestrogens and depression in perimenopausal US women: NHANES 2005-2008. J Affect Disord 2014;156:200-205.
19. Kirschbaum C, Pirke KM, Hellhammer DH. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993;28:76-81.
20. Radloff LS. The CES-D scale a self-report depression scale for research in the general population. Appl Psychol Measure 1977;1:385-401.
21. Boyd JH, Weissman MM, Thompson WD, Myers JK. Screening for depression in community sample. Arch Gen Psychiatry 1982;39:1195-1200.
22. Thomas JL, Jones GN, Scarinci IC, Mehan DJ, Brantley PJ. The utility of the CES-D as a depression screening measure among low-income women attending primary care clinics. Int J Psychiatry Med 2001;31:25-40.
23. Sarason IG, Johnson JH. The life experiences survey: preliminary findings. DTIC Document; 1976.
24. Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol 1978;46:932-946.
25. Leserman J, Petitto J, Gu H, et al. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psy-chol Med 2002;32:1059-1073.
26. Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men: a 2-year follow-up study. Arch Gen Psychiatry 1997;54:279-285.
27. Leserman J, Ironson G, O'Cleirigh C, Fordiani JM, Balbin E. Stressful life events and adherence in HIV. AIDS Patient Care STDS 2008;22: 403-411.
28. Leserman J, Whetten K, Lowe K, Stangl D, Swartz MS, Thielman NM. How trauma, recent stressful events, and PTSD affect functional health status and health utilization in HIV-infected patients in the south. Psychosom Med 2005;67:500-507.
29. Evans DL, Leserman J, Perkins DO, et al. Severe life stress as a predictor of early disease progression in HIV infection. Am J Psychiatry 1997;154:630-634.
30. Greene JG. Constructing a standard climacteric scale. Maturitas 2008;61:78-84.
31. Alder E, Bancroft J, Livingstone J. Estradiol implants, hormone levels and reported symptoms. J Psychosom Obstet Gynecol 1992;13: 223-235.
32. Derman RJ, Dawood M, Stone S. Quality of life during sequential hormone replacement therapy-a placebo-controlled study. Int J Fertil Menopausal Stud 1994;40:73-78.
33. Schneider HP, MacLennan AH, Feeny D. Assessment of health-related quality of life in menopause and aging. Climacteric 2008;11:93-107.
34. Warner R. Applied Statistics: From Bivariate Through Multivariate Techniques. Tousand Oaks, CA: SAGE Publications; 2012.
35. Epperson CN, Sammel MD, Freeman EW. Menopause effects on verbal memory: findings from a longitudinal community cohort. J Clin Endo-crinol Metab 2013;98:3829-3838.
36. Berent-Spillson A, Persad CC, Love T, et al. Hormonal environment affects cognition independent of age during the menopause transition. J Clin Endocrinol Metab 2012;97:E1686-E1694.
37. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 1977;4:31-47.
38. Bachmann GA. Vasomotor flushes in menopausal women. Am J Obstet Gynecol 1999;180:S312-S316.
39. Rubinow DR, Smith MJ, Schenkel LA, Schmidt PJ, Dancer K. Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls. J Affect Disord 2007;104:37-44.
40. Toffoletto S, Lanzenberger R, Gingnell M, Sundström-Poromaa I, Comasco E. Emotional and cognitive functional imaging of estrogen and progesterone effects in the female human brain: a systematic review. Psychoneuroendocrinology 2014;50:28-52.
41. Staebler K, Helbing E, Rosenbach C, Renneberg B. Rejection sensitivity and borderline personality disorder. Clin Psychol Psychother 2011;18:275-283.
42. Leary MR, Twenge JM, Quinlivan E. Interpersonal rejection as a determinant of anger and aggression. Pers Soc Psychol Rev 2006;10:111-132.
43. Twenge JM, Catanese KR, Baumeister RF. Social exclusion and the deconstructed state: time perception, meaninglessness, lethargy, lack of emotion, and self-awareness. J Pers Soc Psychol 2003;85:409-423.
44. Laflamme N, Nappi RE, Drolet G, Labrie C, Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERa and ERb) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J Neurobiol 1998;36:357-378.
45. Hrabovszky E, Kalló I, Steinhauser A, et al. Estrogen receptor-b in oxytocin and vasopressin neurons of the rat and human hypothalamus: immunocytochemical and in situ hybridization studies. J Comparat Neurol 2004;473:315-333.
46. Kruijver FP, Balesar R, Espila AM, Unmehopa UA, Swaab DF. Estrogen receptor-b distribution in the human hypothalamus: similarities and differences with ERa distribution. J Comparat Neurol 2003;466: 251-277.
47. Suzuki S, Handa RJ. Estrogen receptor-b, but not estrogen receptor-a, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: comparison with other neuropeptides. J Comparat Neurol 2005;484:28-42.
48. McQuaid RJ, McInnis OA, Abizaid A, Anisman H. Making room for oxytocin in understanding depression. Neurosci Biobehav Rev 2014;45:305-322.
49. Bartz JA, Zaki J, Bolger N, Ochsner KN. Social effects of oxytocin in humans: context and person matter. Trends Cogn Sci 2011;15:301-309.
50. Kubzansky LD, Mendes WB, Appleton AA, Block J, Adler GK. A heartfelt response: oxytocin effects on response to social stress in men and women. Biol Psychol 2012;90:1-9.
51. Taylor SE, Gonzaga GC, Klein LC, Hu P, Greendale GA, Seeman TE. Relation of oxytocin to psychological stress responses and hypothalamic-pituitary-adrenocortical axis activity in older women. Psychosom Med 2006;68:238-245.
52. Domes G, Lischke A, Berger C, et al. Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 2010;35:83-93.
53. Lischke A, Gamer M, Berger C, et al. Oxytocin increases amygdala reactivity to threatening scenes in females. Psychoneuroendocrinology 2012;37:1431-1438.
54. McConnell DS, Stanczyk FZ, Sowers MR, Randolph JF Jr, Lasley BL. Menopausal transition stage-specific changes in circulating adrenal androgens. Menopause 2012;19:658-663.
55. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 2010;67:598-607.
56. de Novaes Soares C, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529-534.
57. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183:414-420.
58. Joffe H, Petrillo LF, Koukopoulos A, et al. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J Clin Endocrinol Metab 2011;96:E1044-E1054.
59. Creswell JD, Pacilio LE, Lindsay EK, Brown KW. Brief mindfulness meditation training alters psychological and neuroendocrine responses to social evaluative stress. Psychoneuroendocrinology 2014;44:1-12.
60. Hoge EA, Bui E, Marques L, et al. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry 2013;74:786-792.
61. Britton WB, Shahar B, Szepsenwol O, Jacobs WJ. Mindfulness-based cognitive therapy improves emotional reactivity to social stress: results from a randomized controlled trial. Behav Ther 2012;43:365-380.
62. Fjorback L, Arendt M, Ørnbøl E, Fink P, Walach H. Mindfulness-based stress reduction and mindfulness-based cognitive therapy-a systematic review of randomized controlled trials. Acta Psychiatr Scand 2011;124:102-119.
63. Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hébert JR. The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. Breast Cancer Res Treat 2012;131:99-109.